Protalix BioTherapeutics (DE) Statistics
NYSE: PLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.90-0.16 (-5.23%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Protalix BioTherapeutics (DE) by the numbers
Protalix BioTherapeutics (DE) has a market capitalization of $244.5 million based on 84.32M shares outstanding. Its trailing P/E ratio is 12.1, and its forward P/E is 4.7. The stock trades 6.6% above its 50-day average and 18.1% above its 200-day average.
Average daily trading volume is 903.48K shares, or about $2.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PLX valuation vs. peer median
| Metric | PLX | Peer median | Difference |
|---|---|---|---|
| Market cap | $244.52M | $253.13M | -3% |
| Avg. volume | 903.48K | 1.31M | -31% |
Peer median across 8 companies: LXEO, AUTL, EDIT, SABS, EIKN, SCTX, OCGN, AGMB.
Valuation
- Market cap
- $244.52M
- P/E (TTM)
- 12.08
- Forward P/E
- 4.68
- Price / sales (latest FY)
- 4.64
- EPS (TTM)
- $0.24
- Shares outstanding
- 84.32M
Price and trading
- Previous close
- 3.06
- Open
- 3.02
- Day range
- 2.87 – 3.04
- 52-week range
- 1.65 – 3.19
- 52-week change
- +65.71%
- Beta
- —
- Volume
- 1.23M
- Average volume
- 903.48K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 244.52M
- Pe
- 12.08
- Forward Pe
- 4.68
- Eps
- 0.24
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.19
- Week52 Low
- 1.65
- Avg Volume
- 903.48K
- Shares Outstanding
- 84.32M
- Ma50
- 2.72
- Ma200
- 2.45
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -9.09%
- Pct From52w Low
- 75.76%